BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8287377)

  • 1. Occurrence and de novo biosynthesis of follicle stimulating hormone (FSH) in benign and malignant conditions of human breast.
    Garde SV; Sheth AR; Joseph R; Panchal CJ; Chinoy RF; Sheth NA
    Cancer Lett; 1993 Nov; 75(1):1-9. PubMed ID: 8287377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoperoxidase localization and denovo biosynthesis of a 10.5-kDa inhibin in benign and malignant conditions of human breast.
    Sheth AR; Chinoy RF; Garde SV; Panchal CJ; Sheth NA
    Cancer Lett; 1993 Aug; 72(1-2):127-34. PubMed ID: 8402568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues.
    Ohuchi N; Thor A; Page DL; Hand PH; Halter SA; Schlom J
    Cancer Res; 1986 May; 46(5):2511-9. PubMed ID: 3084069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate--an extrapituitary source of follicle-stimulating hormone (FSH): occurrence, localization, and de novo biosynthesis and its hormonal modulation in primates and rodents.
    Garde SV; Sheth AR; Shah MG; Kulkarni SA
    Prostate; 1991; 18(4):271-87. PubMed ID: 1711686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of c-kit in common benign and malignant breast lesions.
    Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
    Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo biosynthesis of FSH like peptide by the human prostate.
    Hurkadli KS; Shah MG; Pardanani DS; Sheth AR
    Life Sci; 1990; 47(5):391-400. PubMed ID: 2118585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular expression of growth hormone and prolactin receptors in human breast disorders.
    Mertani HC; Garcia-Caballero T; Lambert A; Gérard F; Palayer C; Boutin JM; Vonderhaar BK; Waters MJ; Lobie PE; Morel G
    Int J Cancer; 1998 Apr; 79(2):202-11. PubMed ID: 9583737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in tetranectin immunoreactivity between benign and malignant breast tissue.
    Christensen L; Clemmensen I
    Histochemistry; 1991; 95(5):427-33. PubMed ID: 1651300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of hyaluronan in benign and malignant breast lesions.
    Auvinen PK; Parkkinen JJ; Johansson RT; Agren UM; Tammi RH; Eskelinen MJ; Kosma VM
    Int J Cancer; 1997 Oct; 74(5):477-81. PubMed ID: 9355968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical localisation of follicle stimulating hormone (FSH) in normal, benign and malignant human prostates.
    Hurkadli KS; Sheth AR; Garde SV; Doctor VM; Sheth NA
    Br J Cancer; 1990 Feb; 61(2):225-9. PubMed ID: 2106911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of thyroid hormone receptors on breast cancer cell proliferation.
    Conde I; Paniagua R; Zamora J; Blánquez MJ; Fraile B; Ruiz A; Arenas MI
    Ann Oncol; 2006 Jan; 17(1):60-4. PubMed ID: 16282247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
    Zheng WQ; Looi LM; Cheah PL
    Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical studies of S-100 protein expression in myoepithelial cells of benign breast diseases and normal breast tissues.
    Umekita Y; Fujiyoshi T; Takasaki T; Kuriwaki K; Yoshida A; Yoshida H
    In Vivo; 1993; 7(5):415-8. PubMed ID: 8110983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: an immunohistochemical comparison of normal, benign, and malignant breast tissues.
    Costantini V; Sidoni A; Deveglia R; Cazzato OA; Bellezza G; Ferri I; Bucciarelli E; Nenci GG
    Cancer; 1996 Mar; 77(6):1079-88. PubMed ID: 8635127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcoglycans in the normal and pathological breast tissue of humans: an immunohistochemical and molecular study.
    Arco A; Favaloro A; Gioffrè M; Santoro G; Speciale F; Vermiglio G; Cutroneo G
    Cells Tissues Organs; 2012; 195(6):550-62. PubMed ID: 22067288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FSH in testes of marmosets during development: immunocytochemical localization and de novo biosynthesis.
    Garde SV; Sheth AR; Kulkarni SA
    Anat Rec; 1991 Sep; 231(1):119-24. PubMed ID: 1750707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Distribution of actin isoforms in normal, dysplastic, and tumorous human breast cells].
    Dugina VB; Chipysheva TA; Ermilova VD; Gabbiani D; Chaponnier C; Vasil'ev IuM
    Arkh Patol; 2008; 70(2):28-31. PubMed ID: 18540438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical localization of follicle stimulating hormone in normal human stomach.
    Mandrekar PS; Sheth AR; Doctor VM; Zaveri JP; Sheth NA
    Anat Rec; 1990 Jul; 227(3):334-9. PubMed ID: 1695496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of activin on follicle-stimulating hormone secretion and biosynthesis in human glycoprotein hormone-producing pituitary adenomas.
    Alexander JM; Jameson JL; Bikkal HA; Schwall RH; Klibanski A
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1261-7. PubMed ID: 1902844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Steroid hormone receptors in the normal breast and in benign mastopathies].
    Kouyoumdjian JC; Feuilhade F; Pinaudeau Y; Rymer JC
    Bull Cancer; 1986; 73(2):120-3. PubMed ID: 3730631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.